Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Nivolumab improves survival in patients with non-small cell lung cancer in the long-term.

Nivolumab improves survival in patients with non-small cell lung cancer in the long-term.

Posted by on Feb 28, 2021 in Lung cancer | 0 comments

In a nutshell This study looked at 5-year outcomes of patients with previously treated advanced non-small-cell lung cancer (NSCLC) taking nivolumab (Opdivo) compared to docetaxel (Taxotere). The authors found that nivolumab continued to improve the outcomes of these patients after 5 years. Some background NSCLC is the most common...

Read More

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Posted by on Feb 26, 2021 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity. Some background Oligometastatic cancer (OMC)...

Read More

Evaluating S-1 plus cisplatin with radiotherapy for inoperable stage III non-small cell lung cancer

Evaluating S-1 plus cisplatin with radiotherapy for inoperable stage III non-small cell lung cancer

Posted by on Feb 25, 2021 in Lung cancer | 0 comments

In a nutshell This study looked at the use of chemotherapy with S-1 (Teysuno) plus cisplatin (Platinol) versus docetaxel (Taxotere) plus cisplatin and radiotherapy (RT) for stage III non-small-cell lung cancer (NSCLC) that cannot be surgically removed. The authors found that S-1 plus cisplatin (SP) should be considered as a treatment...

Read More

Does anti-cancer therapy improve the outcomes of older patients with metastatic non-small cell lung cancer?

Does anti-cancer therapy improve the outcomes of older patients with metastatic non-small cell lung cancer?

Posted by on Feb 21, 2021 in Lung cancer | 0 comments

In a nutshell This article looked at whether anti-cancer treatments can improve the outcomes of older patients with metastatic (cancer that has spread to a new location) non-small cell lung cancer (mNSCLC). The authors found that outcomes were improved with anti-cancer therapies in these patients. Some background NSCLC is responsible...

Read More

Controlling brain metastasis with localized radiotherapy.

Controlling brain metastasis with localized radiotherapy.

Posted by on Feb 17, 2021 in Lung cancer | 0 comments

In a nutshell This study evaluated the impact of radiotherapy (RT) on controlling brain metastasis (BM). The study suggested that a single dose of RT was effective in controlling small BM. Larger BM could be controlled more effectively with multiple rounds of RT. Some background The spread of cancer from the original tumor to other parts of the body...

Read More

Can tumor mutation burden be used as a predictive biomarker to immune checkpoint inhibitors for non-small cell lung cancer?

Can tumor mutation burden be used as a predictive biomarker to immune checkpoint inhibitors for non-small cell lung cancer?

Posted by on Feb 14, 2021 in Lung cancer | 0 comments

In a nutshell This article looked at the use of tumor mutation burden (TMB) to predict response to immune checkpoint inhibitor (ICI) therapy in patients with non-small cell lung cancer (NSCLC). The authors found that TMB is a promising biomarker that can predict the effectiveness of ICI therapy in advanced NSCLC.  Some background NSCLC...

Read More

COVID-19 Vaccine Clinical Trials: “Part of something bigger than myself”

COVID-19 Vaccine Clinical Trials: “Part of something bigger than myself”

Posted by on Feb 1, 2021 in Blog, Coronavirus / COVID-19, Lung cancer | 0 comments

Barry Nelson, Patient Advisor at Brigham and Women’s Hospital Center for Patients and Families participated in a webinar on January 11 organized by  The Center for Health Education Research Service in Boston, Massachusetts. [1] During the webinar, Nelson described his experience as a cancer survivor.  “I was diagnosed with advanced lung cancer...

Read More

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Posted by on Jan 31, 2021 in Lung cancer | 0 comments

In a nutshell The aim of this study was to evaluate the safety of giving stereotactic radiosurgery (SRS) at the same time as other cancer treatments for patients who have brain metastasis. The study found that SRS given in combination with chemotherapy, immunotherapy, or targeted therapy was safe with low levels of side effects. Some background The...

Read More

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Posted by on Jan 31, 2021 in Lung cancer | 0 comments

In a nutshell The aim of this study was to evaluate the safety of giving stereotactic radiosurgery (SRS) at the same time as other cancer treatments for patients who have brain metastasis. The study found that SRS given in combination with chemotherapy, immunotherapy, or targeted therapy was safe with low levels of side effects. Some background The...

Read More